Organon won a label expansion for the steroid-free topical cream it picked up from its October acquisition of Dermavant.
McKinsey fined $650M for helping boost OxyContin sales, misleading FDA about conflicts. Ex-partner Martin Elling charged with ...
Bicycle Therapeutics shared several batches of data for its bicyclic toxin conjugate in metastatic urothelial ...
The European Medicines Agency’s human medicines committee (CHMP) handed down 17 recommendations for drug approvals on Friday ...
BeiGene acquires MTAP deletion drug SYH2039 from CSPC for $150M, plans combo with BGB-58067, competing with Ideaya's IDE397 ...
Boundless Bio is trimming its oncology pipeline in the wake of disappointing cancer data and switching up its leadership just ...
San Antonio Breast Cancer Conference featured updates on VEGF bispecifics, oral protein degraders, and data from BeiGene, ...
Repare Therapeutics announced that a combination of two targeted drugs resulted in confirmed responses of 19% and 17% in ...
Eisai licenses Newron's evenamide for Asia; Novavax gets $50M from Sanofi; Candel & Inovio price offerings; RemeGen's disitamab vedotin shows success in breast cancer trial ...
In an attempt to continue its I&I dominance beyond Humira, Skyrizi and Rinvoq, AbbVie is buying up another small autoimmune ...
Xaira hires former Roche exec as CMO; 'Tis the season for retirements at Alnylam, Regeneron
The billion-dollar AI-focused startup Xaira Therapeutics deepened its C-suite this week, hiring former Roche executive Paulo ...
Teos Therapeutics halts inupadenant development after poor Phase 2 NSCLC data, and shifts focus to TIGIT program, a combo of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback